HK1016408A1 - Use of a combination of antineoplastons for the manufacture of a medicament for the treatment of neurofibromatosis - Google Patents

Use of a combination of antineoplastons for the manufacture of a medicament for the treatment of neurofibromatosis

Info

Publication number
HK1016408A1
HK1016408A1 HK98115816A HK98115816A HK1016408A1 HK 1016408 A1 HK1016408 A1 HK 1016408A1 HK 98115816 A HK98115816 A HK 98115816A HK 98115816 A HK98115816 A HK 98115816A HK 1016408 A1 HK1016408 A1 HK 1016408A1
Authority
HK
Hong Kong
Prior art keywords
neurofibromatosis
combination
antineoplastons
medicament
manufacture
Prior art date
Application number
HK98115816A
Other languages
English (en)
Inventor
Stanislaw R Burzynski
Original Assignee
Stanislaw R Burzynski
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Stanislaw R Burzynski filed Critical Stanislaw R Burzynski
Publication of HK1016408A1 publication Critical patent/HK1016408A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Activated Sludge Processes (AREA)
HK98115816A 1994-05-04 1998-12-28 Use of a combination of antineoplastons for the manufacture of a medicament for the treatment of neurofibromatosis HK1016408A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/237,772 US5391575A (en) 1994-05-04 1994-05-04 Method for treating neurofibromatosis

Publications (1)

Publication Number Publication Date
HK1016408A1 true HK1016408A1 (en) 1999-10-29

Family

ID=22895101

Family Applications (1)

Application Number Title Priority Date Filing Date
HK98115816A HK1016408A1 (en) 1994-05-04 1998-12-28 Use of a combination of antineoplastons for the manufacture of a medicament for the treatment of neurofibromatosis

Country Status (8)

Country Link
US (1) US5391575A (xx)
EP (1) EP0680756B1 (xx)
AT (1) ATE183390T1 (xx)
AU (1) AU683145B2 (xx)
DE (1) DE69511453T2 (xx)
ES (1) ES2139774T3 (xx)
HK (1) HK1016408A1 (xx)
ZA (1) ZA953500B (xx)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5391575A (en) * 1994-05-04 1995-02-21 Burzynski; Stanislaw R. Method for treating neurofibromatosis
US6127419A (en) * 1998-11-23 2000-10-03 Burzynski; Stanislaw R. Phenylacetic acid compositions for treating or preventing atherosclerosis and restenosis
US6987131B1 (en) * 2000-06-26 2006-01-17 Burzynski Stanislaw R Phenylacetic acid compositions for treating or preventing hypercholesterolemia
IL154536A0 (en) 2000-08-29 2003-09-17 Nobex Corp Immunoregulatory compounds and derivatives and methods of treating diseases therewith
US8048924B2 (en) * 2001-08-29 2011-11-01 Biocon Limited Methods and compositions employing 4-aminophenylacetic acid compounds
ES2565848T3 (es) 2004-07-07 2016-04-07 Biocon Limited Síntesis de compuestos inmunorreguladores unidos por grupos azoicos
US20060205818A1 (en) * 2005-03-08 2006-09-14 Burzynski Stanislaw R Method for the treatment of von Hippel-Lindau (VHL) disease with phenylacetyl-derivatives

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4559325A (en) * 1981-12-15 1985-12-17 Burzynski Stanislaw R Purified antineoplaston fractions and methods of treating neoplastic disease
US5227292A (en) * 1990-07-12 1993-07-13 University Of Utah Neurofibromatosis type 1 gene
US5244922A (en) * 1990-09-04 1993-09-14 Burzynski Stanislaw R Methods for treating viral infections
US5116622A (en) * 1990-09-12 1992-05-26 Burzynski Stanislaw R Methods for treating parkinson's disease
US5391575A (en) * 1994-05-04 1995-02-21 Burzynski; Stanislaw R. Method for treating neurofibromatosis

Also Published As

Publication number Publication date
DE69511453T2 (de) 1999-12-09
EP0680756B1 (en) 1999-08-18
DE69511453D1 (de) 1999-09-23
ATE183390T1 (de) 1999-09-15
AU1777595A (en) 1995-11-09
EP0680756A1 (en) 1995-11-08
US5391575A (en) 1995-02-21
ZA953500B (en) 1996-05-29
AU683145B2 (en) 1997-10-30
ES2139774T3 (es) 2000-02-16

Similar Documents

Publication Publication Date Title
ES2077530A1 (es) Procedimiento para la preparacion de productos farmaceuticos para curar enfermedades tumorales.
EP0509317A3 (en) Use of droloxifene in the treatment of bone diseases
MA23170A1 (fr) Procede de preparation d'un nouveau compose .
HUP9800794A2 (hu) (S)-oxi-butinin és (S)-dezetil-oxi-butinin alkalmazása vizelet inkontinencia kezelésére alkalmazható gyógyszerkészítmények előállítására és a vegyületek előállítása
GEP20002300B (en) Purified Forms of Dnase, Method for Its Production, Pharmaceutical Composition and Use Thereof
ATE146677T1 (de) Pharmazeutische formulierung zur behandlung der nicotinabhängigkeit
MY106528A (en) Method of treating impotence.
PT914110E (pt) Metodo de modulacao da micro-circulacao
PL320687A1 (en) Use of incense for treating alzheimer disease
PH30083A (en) Treatment of lower urinary tract disorders
DK0668077T3 (da) Produkter, som indeholder G-CSF og TNF-bindende protein
DK0856312T3 (da) Anvendelse af trospiumchlorid til fremstilling af et lægemiddel til behandling af blæresygdomme
HK1016408A1 (en) Use of a combination of antineoplastons for the manufacture of a medicament for the treatment of neurofibromatosis
GR3036071T3 (en) Use od moxonidine for the Treatment of neuropathic pain
ITRM910730A1 (it) Composizioni farmaceutiche, per uso topico, contenenti "scavengers" di radicali liberi dell'ossigeno e antibatterici, indicate nella terapia dei tessuti superficiali.
ATE204476T1 (de) Verwendung von 3,5-diamino-6-(2,3-dichlorophenyl)-1,2,4-triazi e zur herstrllung eines medikaments zur behandlung von bestimmten schmerzen und ödem
ATE178208T1 (de) Capsaicin enthaltendes arzneimittel zur behandlung chronischer rhinopathie
EP0642338A1 (en) USE OF (E) - 2 - (P -FLUOROPHENETHYL) - 3 - FLUOROALLYLAMINE FOR TREATING ALZHEIMER'S DISEASE.
EP0673646A3 (de) Verwendung von Deoxyspergualin zur Herstellung eines Arzneimittels zur Behandlung von entzündlich-hyperreaktiven Erkrankungen.
Azizbekov et al. Effects of magnetic induction on bacterial wound contamination in children.
RU94000695A (ru) Средство с противоаллергическим действием
CA2161683A1 (en) Veterinary composition containing a proton pump inhibitor
CN1050824A (zh) 一种根治白癜风病的药的配制方法

Legal Events

Date Code Title Description
PF Patent in force
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20140503